STAR Systems International Introduces the Falcon Dual Frequency Transponder for Tolling
Notified -
Globe Newswire6-05-2025, 21:30
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00